This page lists the SEC filings reported by MACQUARIE GROUP LTD.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | HANCOCK WHITNEY CORP | 4,321,985 | 5.0% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | FIRST INTERSTATE BANCSYSTEM INC | 2,433,475 | 3.9% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | UNIVERSAL DISPLAY CORP \PA\ | 733,325 | 1.6% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | ACI WORLDWIDE, INC. | 505,576 | 0.4% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | Great Western Bancorp, Inc. | 4,106,768 | 7.4% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | Neenah Inc | 1,117,194 | 6.7% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | Pacira BioSciences, Inc. | 4,205,522 | 9.4% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | PATTERSON UTI ENERGY INC | 12,980,732 | 6.0% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | RPT Realty | 7,385,420 | 8.8% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | Tabula Rasa HealthCare, Inc. | 1,782,292 | 6.9% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | Travere Therapeutics, Inc. | 3,767,892 | 6.2% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | FIRST FINANCIAL BANCORP /OH/ | 6,009,284 | 6.4% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | LIGAND PHARMACEUTICALS INC | 624,969 | 3.7% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | ARTIVION, INC. | 2,218,512 | 5.6% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | J&J SNACK FOODS CORP | 1,029,680 | 5.4% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | KAISER ALUMINUM CORP | 814,532 | 5.1% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | MALIBU BOATS, INC. | 2,118,481 | 10.2% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | SOHU COM INC | 3,523,045 | 9.0% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | TTM TECHNOLOGIES INC | 5,406,270 | 5.2% | EDGAR |
| SC 13G/A | 2022-02-14 | MACQUARIE GROUP LTD | Vanda Pharmaceuticals Inc. | 2,913,471 | 5.2% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.